Yuyu Pharma (000220) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, Yuyu Pharma (000220) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩836.62 Million ≈ $566.97K USD) by net assets (₩139.10 Billion ≈ $94.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Yuyu Pharma fund operations to measure how many days the company can operate on defensive assets alone.

Yuyu Pharma - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Yuyu Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Yuyu Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yuyu Pharma ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Enwell Energy plc F:RHN	-0.003x
SINCLAIRS HOTELS ORD (BSE) NSE:SINCLAIR	N/A
Scan-D TWO:6195	0.192x
Pembangunan Jaya Ancol Tbk JK:PJAA	0.107x
EPE Capital Partners Ltd JSE:EPE	-0.059x
Ctac N.V AS:CTAC	-0.292x
Hsinjing Holding Co Ltd TWO:3713	0.028x
Heritage Global Inc NASDAQ:HGBL	-0.032x

Annual Cash Flow Conversion Efficiency for Yuyu Pharma (2011–2024)

The table below shows the annual cash flow conversion efficiency of Yuyu Pharma from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Yuyu Pharma.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩135.06 Billion ≈ $91.53 Million	₩24.95 Billion ≈ $16.91 Million	0.185x	+5182.83%
2023-12-31	₩120.36 Billion ≈ $81.56 Million	₩420.86 Million ≈ $285.21K	0.003x	+106.93%
2022-12-31	₩123.37 Billion ≈ $83.61 Million	₩-6.23 Billion ≈ $-4.22 Million	-0.050x	-244.10%
2021-12-31	₩128.69 Billion ≈ $87.21 Million	₩4.51 Billion ≈ $3.06 Million	0.035x	+253.64%
2020-12-31	₩117.04 Billion ≈ $79.31 Million	₩-2.67 Billion ≈ $-1.81 Million	-0.023x	-115.66%
2019-12-31	₩90.54 Billion ≈ $61.36 Million	₩13.19 Billion ≈ $8.94 Million	0.146x	+107.05%
2018-12-31	₩86.87 Billion ≈ $58.87 Million	₩6.11 Billion ≈ $4.14 Million	0.070x	+937.85%
2017-12-31	₩82.83 Billion ≈ $56.14 Million	₩561.35 Million ≈ $380.42K	0.007x	-94.60%
2016-12-31	₩78.29 Billion ≈ $53.06 Million	₩9.82 Billion ≈ $6.65 Million	0.125x	+179.12%
2015-12-31	₩73.73 Billion ≈ $49.97 Million	₩-11.68 Billion ≈ $-7.92 Million	-0.158x	-930.90%
2014-12-31	₩71.49 Billion ≈ $48.45 Million	₩1.36 Billion ≈ $923.95K	0.019x	+277.82%
2013-12-31	₩72.28 Billion ≈ $48.98 Million	₩-775.17 Million ≈ $-525.32K	-0.011x	-111.45%
2012-12-31	₩69.50 Billion ≈ $47.10 Million	₩6.51 Billion ≈ $4.41 Million	0.094x	-5.64%
2011-12-31	₩67.23 Billion ≈ $45.56 Million	₩6.67 Billion ≈ $4.52 Million	0.099x	--

About Yuyu Pharma

KO:000220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$43.48 Million

₩64.16 Billion KRW

Market Cap Rank

#22479 Global

#1426 in Korea

Share Price

₩3965.00

Change (1 day)

-2.70%

52-Week Range

₩3640.00 - ₩4770.00

All Time High

₩16106.03